(Q83492372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

C F Spraggs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

L R Parham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C M Hunt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C T Dollery

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

22 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

647-652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

Monitoring for hepatotoxicity: what is the predictive value of liver "function" tests?

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Case definition and phenotype standardization in drug-induced liver injury.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Gilbert's syndrome: an overview for clinical biochemists

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Pharmacogenetics of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Gastrosplenic fistula from Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Outcome and prognostic markers in severe drug-induced liver disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Drug-induced liver injury: Hy's rule revisited

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.277

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22357454%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference